Manufacturer: Sanofi India Ltd
Salt Composition : Meningococcal Vaccine(Group A, C, Y & W-135)(4mcg)
Menactra Vaccine is given by a healthcare professional and should not be self-administered. It is important to receive all the doses of the vaccine to be effective. A single booster dose may be given to individuals 15 through 55 years of age at continued risk for meningococcal disease, if at least 4 to 6 years have elapsed since the prior dose. Do not administer this product intravenously, subcutaneously, or intradermally.
Some common side effects of this medicine include injection site reactions (such as pain, swelling, redness), irritability, loss of appetite, sleepiness, headache, nausea, vomiting, and diarrhea. If these side effects do not go away with time or get worse, let the doctor know. The doctor may help with ways to reduce or prevent these symptoms.
To make sure the vaccine is safe, before receiving the vaccine, it is important to let the doctor know if you have any other illnesses. You should also tell the doctor about all the medicines you are taking. Pregnant and breastfeeding mothers should consult and seek advice from their doctor before receiving the vaccine.
Menactra Vaccine contains Meningococcal Polysaccharides of serogroups A, C, Y, and W-135 antigens. It also contains diphtheria toxoid protein, that acts as a carrier for the individual serogroup antigens. This vaccine helps develop immunity by initiating a mild infection. This type of infection does not cause illness but stimulates the body's immune system to produce antibodies (proteins) to protect against any future infections.
The presence of bactericidal anti-capsular meningococcal antibodies has been associated with protection from invasive meningococcal disease. Menomune - A/C/Y/W-135 vaccine induces the production of bactericidal antibodies specific to the capsular polysaccharides of serogroups A, C, Y, and W-135.
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Menactra
Irritability
Injection site reactions (pain, swelling, redness)
Loss of appetite
Sleepiness
Headache
Nausea
Vomiting
Diarrhea
Erythema (skin redness)
Do not administer meningococcal vaccines to: A person who has ever had a severe allergic reaction (e.g., anaphylaxis) after a previous dose. A person who has a severe allergy to any vaccine component.
Menactra Vaccine may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
It is not known whether it is safe to consume alcohol with Menactra Vaccine. Please consult your doctor.
Information regarding the use of Menactra Vaccine during breastfeeding is not available. Please consult your doctor.
Be sure to notify your doctor of any side effects that occur after you receive this vaccine. This vaccine may cause serious allergic reactions, including anaphylaxis, which can be life-threatening and require immediate medical attention.
There may be an interaction between meningococcal vaccine and any of the following: acetaminophen. acetylsalicylic acid (ASA) immunosuppressants.
Store in a refrigerator (2 - 8°C). Do not freeze.
Consult a doctor before taking any medicines.
Consult a doctor before taking any medicines.
Menactra Vaccine is used for active immunization to prevent meningococcal disease in individuals 9 months through 55 years of age.
In children 9 through 23 months of age, Menactra Vaccine is given as a 2-dose series at least three months apart.
In individuals 2 through 55 years of age, it is given as a single dose.
Your doctor or nurse will guide you how to use this medicine.
